TrialClinical cancer research : an official journal of the American Association for Cancer Research2019

Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis.

Daniel J George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.